A new biotech company focused on innovative genes to cure and detect cancer.
Our advisors have vast experience in business development, R&D in biotechnology and cancer, venture capital, drug and biomarker discovery and public financing.
Plus Vitech’s investors and shareholders include 3Fs and Business Angels.
The founders of Plus Vitech, S.L. are Vicente Salinas, MD, PhD and Carmen Lara, MBA.
For a long time now doctors, scientists and patients have required identifiable, non-invasive genetic cancer biomarkers indicating the presence of disease and innovative therapies which can achieve real clinical results.
The company has a collaboration framework with the Servicio Andaluz de Salud (SAS), through the Fundación Pública Andaluza Progreso y Salud (FPS), and with the Universidad de Salamanca in order to carry out the Plus Vitech’s projects.